Diana M. Escolar - Concepedia

Author

Diana M. Escolar

Also Known As

D. Escolar, D. M. Escolar, D.M. Escolar, Diana Escolar, Diana M Escolar, Diana M. Escolar, Escolar, D, Escolar, D.M., Escolar, Diana

100

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Children's National Washington University in St. Louis George Washington University Children's Hospital of Richmond at VCU Kennedy Krieger Institute

About

Diana M. Escolar is an author at Children's National specializing in medicine, pathology, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	904
2	Health Sciences	3	3	405
3	Applied Physiology	2	2	226
4	Engineering	1	1	22
5	Public Health	1	1	28

Diana M. Escolar

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease Ans T. van der Ploeg, Paula R. Clemens, Deyanira Corzo, New England Journal of Medicine	2010	726
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy Kathryn R. Wagner, James L. Fleckenstein, Anthony A. Amato, Annals of Neurology	2008	457
Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb–MyoD pathways in muscle regeneration Marina Bakay, Zuyi Wang, Gisela Melcon, Brain	2006	323
Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations Kathryn R. Wagner, Sherifa A. Hamed, Donald W. Hadley, Annals of Neurology Translational MedicineGentamicin TreatmentMendelian DisorderSkeletal MuscleGenetic Disorder	2001	256
Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children Diana M. Escolar, Erik Henricson, J. Mayhew, Muscle & Nerve	2001	249
Myostatin inhibitor ACE‐031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo‐controlled clinical trial Craig Campbell, Hugh J. McMillan, Jean K. Mah, Muscle & Nerve	2016	220
The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures Erik Henricson, Richard T. Abresch, Avital Cnaan, Muscle & Nerve	2013	197
PIP <sub>2</sub> binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome Matthew R. Donaldson, Judy L. Jensen, Martin Tristani‐Firouzi, Neurology	2003	186
Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE Michio Hirano, Ramón Martí, Carlo Casali, Neurology Transplantation MedicineImmunologyPathologyTranslational MedicineTp Activity	2006	179
The cooperative international neuromuscular research group duchenne natural history study—a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used Craig M. McDonald, Erik Henricson, Richard T. Abresch, Muscle & Nerve	2013	175

Page 1